Cargando…

Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service

With the unregulated drug supply—particularly the unregulated opioid supply—becoming increasingly more toxic, more contaminated, and less predictable, drug checking has emerged as an essential public health service: informing individuals who use drugs, as well as those who care and advocate for them...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Hayley, McDonald, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418928/
https://www.ncbi.nlm.nih.gov/pubmed/37569026
http://dx.doi.org/10.3390/ijerph20156486
_version_ 1785088386594242560
author Thompson, Hayley
McDonald, Karen
author_facet Thompson, Hayley
McDonald, Karen
author_sort Thompson, Hayley
collection PubMed
description With the unregulated drug supply—particularly the unregulated opioid supply—becoming increasingly more toxic, more contaminated, and less predictable, drug checking has emerged as an essential public health service: informing individuals who use drugs, as well as those who care and advocate for them, in real-time. For those looking to offer drug checking services in community settings, choosing a technology can be an arduous task. With very little regulatory oversight of drug checking technologies, it can be difficult for organizations that specialize in harm reduction to ascertain what questions to ask drug checking technology vendors to ensure they invest in a technology that best suits the needs of their community. Looking to help those that lack drug checking and technical expertise, Toronto’s Drug Checking Service has compiled a list of questions to equip organizations to make informed decisions when it comes to purchasing drug checking technologies. Having developed and operated a drug checking service since 2018, Toronto’s Drug Checking Service is uniquely positioned to share its expertise and insights.
format Online
Article
Text
id pubmed-10418928
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104189282023-08-12 Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service Thompson, Hayley McDonald, Karen Int J Environ Res Public Health Opinion With the unregulated drug supply—particularly the unregulated opioid supply—becoming increasingly more toxic, more contaminated, and less predictable, drug checking has emerged as an essential public health service: informing individuals who use drugs, as well as those who care and advocate for them, in real-time. For those looking to offer drug checking services in community settings, choosing a technology can be an arduous task. With very little regulatory oversight of drug checking technologies, it can be difficult for organizations that specialize in harm reduction to ascertain what questions to ask drug checking technology vendors to ensure they invest in a technology that best suits the needs of their community. Looking to help those that lack drug checking and technical expertise, Toronto’s Drug Checking Service has compiled a list of questions to equip organizations to make informed decisions when it comes to purchasing drug checking technologies. Having developed and operated a drug checking service since 2018, Toronto’s Drug Checking Service is uniquely positioned to share its expertise and insights. MDPI 2023-07-31 /pmc/articles/PMC10418928/ /pubmed/37569026 http://dx.doi.org/10.3390/ijerph20156486 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Opinion
Thompson, Hayley
McDonald, Karen
Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service
title Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service
title_full Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service
title_fullStr Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service
title_full_unstemmed Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service
title_short Considerations for Purchasing Drug Checking Technologies: Perspectives from Toronto’s Drug Checking Service
title_sort considerations for purchasing drug checking technologies: perspectives from toronto’s drug checking service
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418928/
https://www.ncbi.nlm.nih.gov/pubmed/37569026
http://dx.doi.org/10.3390/ijerph20156486
work_keys_str_mv AT thompsonhayley considerationsforpurchasingdrugcheckingtechnologiesperspectivesfromtorontosdrugcheckingservice
AT mcdonaldkaren considerationsforpurchasingdrugcheckingtechnologiesperspectivesfromtorontosdrugcheckingservice